Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies (OPALE)

University Hospital, Rouen

Status: Active, not recruiting

Conditions: Metastatic Prostate Adenocarcinoma

Treatments: Drug: Local chemotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT03611686

2017/090/HP

Details and patient eligibility

About

Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration

Enrollment: 219 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient monitored for castration-resistant metastatic prostate
• Patients starting a first or second line treatment as part of castration resistance
• Patient not objecting to the study after reading the information letter
• Patient aged over 18 years

Exclusion criteria

• Patient monitored for non-metastatic prostate cancer
• Patient monitored for castration-nonresistant prostate cancer
• Patient not able to understand the information letter

Trial design

219 participants in 1 patient group

patient followed for metastatic prostate adenocarcinoma

Description:

patient wil be followed for metastatic prostate adenocarcinoma during 3 years

Treatment:

Drug: Local chemotherapy